In-Depth Analysis of CELU (Celularity Inc.) Stock: Next-Generation Cell Therapy Innovation and the Essence of Stock Price Volatility
In-Depth Analysis of CELU (Celularity Inc.) Stock: Next-Generation Cell Therapy Innovation and the Essence of Stock Price Volatility※ As the next-generation cell therapy market rapidly emerges, the American biotech company CELU (Celularity Inc.) is drawing global investors' attention. The company is driving forward the development of therapeutics for various indications based on its innovative c..
U.S. AFMD Stock Analysis: Key Drivers of Growth and Decline, Technical Trends, and Investment Strategies
U.S. AFMD Stock Analysis: Key Drivers of Growth and Decline, Technical Trends, and Investment Strategies※ AFMD (Affimed NV), headquartered in Germany and listed on NASDAQ, is a biopharmaceutical company specializing in immuno-oncology therapies. AFMD focuses on developing innovative immunotherapies that harness the body’s natural killer (NK) cells and T cells to combat cancer.The company’s propr..